Your session is about to expire
← Back to Search
Hyperthermia + Chemotherapy for Advanced Gynecological & Breast Cancers
Study Summary
This trial is testing how effective chemotherapy is when combined with hyperthermia (raising body temperature to kill tumor cells) in treating metastatic breast, ovarian, endometrial, or cervical cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- My lung function is good, and I have no history of lung or heart disease.My liver functions are within normal limits.I don't have seizures or brain disorders, and my brain scan is clear.Less than 80% of my liver is affected by disease.I can take care of myself and am up more than 50% of my waking hours.I have never had a lymphoproliferative disorder.I have a confirmed diagnosis of advanced cancer in the breast, ovary, uterus, or cervix.My cancer has not spread to my brain.I haven't had any cancer, except for skin cancer, in the last 5 years.Less than 30% of my lungs are affected by the disease.I am currently taking heart or blood thinning medications.My kidney function tests are within the required range.I have symptoms of heart disease.My kidney function is reduced with a creatinine clearance below 45 mL/min.I have seizures or other brain disorders.I have a history of blood clots.I have never had cancer before.I am younger than 18 years old.I have had a heart attack before.My blood pressure frequently changes.I have a history of heart or lung disease.I have diabetes.My heart is healthy with no history of heart attacks or unstable blood pressure.I do not have diabetes or any serious illness.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers currently looking for new participants for this trial?
"Unfortunately, this particular clinical trial is not presently looking for candidates according to the most recent information found on clinicaltrials.gov. This study was initially posted on 11/1/1997 and was most recently updated on 4/29/2009; however, there are many other studies that are still enrolling patients."
Will this medication produce any harmful side effects?
"This is a Phase 2 trial, meaning that while there are some data supporting safety, there are no data yet supporting efficacy. As such, our team at Power has given it a score of 2."
Share this study with friends
Copy Link
Messenger